Nano X Imaging Ltd(NNOX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Nov 3 at 4:33 AM ET (Korea 11/3 18:33)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -1.71 | Insider Own | 7.37% | Shs Outstand | 78.6M | Perf Week | -12.06% |
| Market Cap | 0.02B | Forward P/E | - | EPS next Y | 64.12% | Insider Trans | 4.19% | Shs Float | 72.8M | Perf Month | -52.49% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | -0.15 | Inst Own | 12.23% | Short Float | 8.38% | Perf Quarter | -71.78% |
| Income | -0.12B | P/S | 1.52 | EPS this Y | -8.91% | Inst Trans | -13.68% | Short Ratio | 5.4 | Perf Half Y | -83.85% |
| Sales | 0.02B | P/B | 0.29 | EPS next 5Y | 38.74% | ROA | -84.82% | Short Interest | 6.10M | Perf YTD | -89.21% |
| Book/sh | 1.03 | P/C | 0.77 | EPS past 3/5Y | 18.87% 1.18% | ROE | -98.98% | 52W High | -93.58% ($4.70) | Perf Year | -91.68% |
| Cash/sh | 0.39 | P/FCF | - | Sales past 3/5Y | 14.93% - | ROIC | -153.1% | 52W Low | 8.13% ($0.28) | Perf 3Y | -94.78% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -89.07% | Gross Margin | -79.87% | Volatility(W/M) | 10.56% 9.46% | Perf 5Y | -98.73% |
| Dividend TTM | - | EV/Sales | 0.03 | Sales Y/Y TTM | 31.52% | Oper. Margin | -387.33% | ATR (14) | 0.04 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.59 | EPS Q/Q | -244.36% | Profit Margin | -747.2% | RSI (14) | 20.87 | Recom | 1.67 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.84 | Sales Q/Q | 36.71% | SMA20 | -30.42% ($0.43) | Beta | 1.36 | Target Price | $4.13 |
| Payout | - | Debt/Eq | 0.11 | Earnings | 2026/9/9 | SMA50 | -51.4% ($0.62) | Rel Volume | 0.71 | Prev Close | $0.33 |
| Employees | 197 | LT Debt/Eq | 0.05 | EPS/Sales Surpr. | -387.65% -22.69% | SMA200 | -80.93% ($1.57) | Avg Volume(3M) | 1.13M | Price | $0.3 |
| IPO | 2020/8/21 | Option/Short | Yes/Yes | Trades | 1289 | Volume | 797,572 | Change | -8.51% |
🩻 Nano-X Imaging is a healthcare company that develops medical imaging diagnostic technologies. The company aims to broaden access to diagnostics by combining digital X-ray imaging systems with AI-powered image interpretation and teleradiology services. Based in Israel, it operates in the global medical device market and is a growth-stage company focused on expanding access to low-cost imaging diagnostic infrastructure.
Over the past 1 year, on the lower side
94% below its 1-year high.
Traded less than usual. That is 71% of its average volume.
NNOX has a sound balance sheet but weak earning power
Losses exceed revenue. The business is barely earning yet.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by -8.9% this year.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $152. Peers typically go for $145.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -98.7%. The S&P 500 did +63% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 12.2%.
Tap to view numbers
It ranks #106 of 140 in the industry
Based on market cap of $24M.
NSYS#103 Nortech Systems Inc $32M PER 31.6 
QTI#104 QT Imaging Holdings Inc $31M PER - 
NSPR#105 InspireMD Inc $25M PER - NNOX#106 Nano X Imaging Ltd $24M PER - 
PMI#107 Picard Medical Inc $21M PER - 
FAQ
What kind of company is NNOX?
NNOX belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of NNOX?
The market cap of NNOX is approximately $24M, ranking 5,148 within its sector.
What is the 52-week high and low for NNOX?
NNOX has recorded a 52-week high of $4.70 and a low of $0.28.
